These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9935236)

  • 1. Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells.
    Turco A; Coppa A; Aloe S; Baccheschi G; Morrone S; Zupi G; Colletta G
    Int J Cancer; 1999 Jan; 80(1):85-91. PubMed ID: 9935236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway.
    Nicolussi A; D'Inzeo S; Gismondi A; Coppa A
    Clin Exp Metastasis; 2006; 23(5-6):237-48. PubMed ID: 17086361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
    Chang W; Parra M; Ji C; Liu Y; Eickelberg O; McCarthy TL; Centrella M
    Gene; 2002 Oct; 299(1-2):65-77. PubMed ID: 12459253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
    J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
    Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
    Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity.
    Le Roy C; Maisnier-Patin K; Leduque P; Li JY; Saez JM; Langlois D
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):87-98. PubMed ID: 10630409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
    Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
    Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
    Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
    Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
    Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
    Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.
    Bulus NM; Sheng HM; Sizemore N; Oldham SM; Barnett JV; Coffey RJ; Beauchamp DR; Barnard JA
    Neoplasia; 2000; 2(4):357-64. PubMed ID: 11005570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells.
    Turco A; Scarpa S; Coppa A; Baccheschi G; Palumbo C; Leonetti C; Zupi G; Colletta G
    Exp Cell Res; 2000 Feb; 255(1):77-85. PubMed ID: 10666336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.